Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 34.07% | 37.14% | 26.79% | 17.35% | 6.27% |
| Total Depreciation and Amortization | 74.02% | 113.04% | 22.17% | -21.34% | -49.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.72% | -39.10% | -14.12% | 14.98% | 42.13% |
| Change in Net Operating Assets | 5.50% | -32.17% | 74.93% | 912.08% | 959.79% |
| Cash from Operations | 112.89% | 69.74% | 61.73% | 67.05% | 66.21% |
| Capital Expenditure | 100.00% | 85.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 40,717.39% | 46,795.00% | -- | -- | -- |
| Total Debt Issued | -1,598.86% | -5,263.02% | 365.82% | -69.29% | -95.18% |
| Total Debt Repaid | -30.38% | -7.63% | 75.52% | 52.43% | 73.45% |
| Issuance of Common Stock | -- | -- | -99.05% | -77.15% | -57.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 497.89% | 497.89% | 345.51% |
| Cash from Financing | -400.06% | -319.28% | -56.51% | -65.22% | -68.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.15% | 91.36% | 153.47% | 52.54% | -148.46% |